Navigation Links
Topcon PS-9 Manual Blocker

ProductsTopcon PS-9 Manual Blocker
Company Topcon America Corporation
Item Topcon PS-9 Manual Blocker
Features 
  • Accentuates TOPCON Edger Line With Fast and Easy Blocking with Optimal Precision
  • Improved Illumination Ensures Maximum Clarity Even on Darker Tinted Lenses
  • Easy Blocking with Adjustable Scale for All Types of Single Vision and Multifocal Lenses
  • Handles Up to 75mm Diameter Lens Blanks
    • Description 
    Info Topcon America Corporation
    Customer Service: (800) 223-1130
    Web site: http://www.topcon.com/home.html

    Related medicine products :

    1. Topcon Trial Frame
    2. Topcon IS-2000 Instrument Stand
    3. Topcon IDS-200 Instrument Delivery System
    4. Topcon CP-5D Chart Projector
    5. Topcon ACP-8R Chart Projector
    6. Topcon MC-3 Chart Projector
    7. Topcon TLS-FD trial lens set
    8. Topcon IMAGEnet 2000 FA/Color System with 800 x 600 pixels
    9. Topcon IMAGEnet 2000 FA/Color System with 3,072 x 2,048 pixels
    10. Topcon IMAGEnet 2000 FA/ICG System with 1024 x 1024 pixels
    11. Topcon Telemedicine System
    Spinal Concepts has developed a versatile set of instruments intended to make posterior lumbar interbody fusion procedures precise, simple and quick every time. The Harmony PLIF Instrument Set is the
    Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide.
    Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide.
    OSV II Smart ValveTM, Hakim, H-V Lumbar Valve system is the intelligent choice for meeting the complex demands of hydrocephalus shunting. Automatic pressure response causes the valve to adjust automa
    Medicine Products:
    (Date:10/13/2008)...ges Latinos to Get Tested, LOS ANGELES, Oct. 13 /...half of all newly diagnosed HIV/AIDS cases,reporte...ionally., -- A week of activities aimed at raisin...ting to coincide with National Latino AIDS Awarene...r Community, Our Responsibility: Latinos in Action...
    (Date:10/13/2008)...n ever before, study finds , , MONDAY,...ver are being treated for high blood pressure, say...nd Blood Institute. , The major factor in the d...igh blood pressure appears to be the obesity epide...dditional efforts are needed to prevent hypertensi...
    (Date:10/13/2008)...g advances study Study needed because of low... 13 /PRNewswire/ -- Advanced Circulatory Systems, ...ced today that it has received,an additional $1.5 ...,Health (NIH) to continue a study testing two devi...rdiac arrest outside a hospital. Parts of Oakland,...
    (Date:10/13/2008)...valve.com ) announced today that the expanded clin...aneous aortic valve replacement (PAVR) in high-ris...l patients at an accelerating pace. More than 1,80...ly 100 centers in 20 countries. , ...er 13, 2008 -- During the Monday Transcatheter Ao...
    Breaking Medicine News(10 mins):Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Blood Pressure on the Rise in America 2Health News:Blood Pressure on the Rise in America 3Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2
    ...ofi-Aventis, one of the world's leading pharmaceut... Taxotere (docetaxel) improves survival in patient... clinical trial named TAX 327 compared Taxotere pl...one) plus prednisone. The study included a little ...
    ...nagers who use mobile phones for many hours a day ...ay develop psychological disorders, says a study t...s. // Francisca Lopez Torrecillas, a lecturer at t...chological assessment and treatment of the Univers...
    ...ian belief and knowledge are great healers and 140...rently in Delhi to study this value system. // "Th...tal role in dealing with mental health issues and ...re about it," said Patrick Bantman, a psychiatrist...
    ...en aiming to shed after-pregnancy pounds should ad...cording to a new study by Harvard researchers. // ...isk for weight gain in women,” said lead author Em...n that early postpartum period — such as diet, tel...
    Other Medicine News:Health News:Mobile Phone Addiction may Cause Psychological Problems 2Health News:Simple Solutions to Postpartum Weight Retention 2
    (Date:10/13/2008)...n January 2009 and Final Trial ...t. 13 /- Neurobiological,Te...nnounced that following a,meeting with the U.S. Fo...(TM) (ancrod) Phase 3 clinical program for acute i...nd analyze data from its two concurrently,running ...
    (Date:10/13/2008)... Facet Solutions, Inc. today,announced the complet...S,IDE Pilot Study. The results show a 78% reductio...n 80% reduction in Visual Analog Scores (VAS) for,... for Facet Solutions,added, "We are very pleased ...demonstrate significant pain relief but the safety...
    (Date:10/12/2008)...signed for more uniform drug ..., Oct. 12 /- Boston,Scienti...rehensive data from,the TAXUS ATLAS clinical progr... single-arm, historically controlled trials, which...ng Stent System in a variety of,lesions and patien...
    (Date:10/10/2008)...0 /-,XTENT, Inc. (Nasdaq: ...ng-term follow-up data from the CUSTOM I, II and I... Research Foundation,s (CRF) twentieth annual,Tran...g in Washington, DC.,The CUSTOM clinical trials ar...safety and efficacy of the Custom NX(R) drug eluti...
    Breaking Medicine Technology:Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Eklin Medical Reports Record Revenues for 2007 3303 1Eklin Medical Reports Record Revenues for 2007 3303 2Eklin Medical Reports Record Revenues for 2007 3303 3Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 1Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 2Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 3Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 4Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 1Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 2Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 1Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 2Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 3
    ...Analysis Shows Statistically Significant Changes i...alif., March 26, 2007 /PRNewswire-FirstCall/ --,Al...e initial,results from its Phase IIa clinical tria...c patients with acute agitation. The 10 mg,dose of...rial,which was a statistically-significant reduct...
    ...d CAPTURE 2 Findings Suggest Improved Outcomes in ...26, 2007 /PRNewswire-FirstCall/ --,Positive 30-day...tid stenting can be performed with positive result...ience in real-world,(non-clinical trial) settings ...urgery. Interim results from the first 1,500,patie...
    Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4